NYSE: EHABEnhabit Inc Stock
$9.27-0.07 (-0.75%)
Updated Jun 20, 2025
EHAB Price
$9.27
Fair Value Price
N/A
Market Cap
$469.41M
52 Week Low
$6.85
52 Week High
$10.91
P/E
-3.36x
P/B
0.86x
P/S
0.43x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.03B
Earnings
-$138.60M
Gross Margin
49%
Operating Margin
-9.19%
Profit Margin
-13.4%
Debt to Equity
1.22
Operating Cash Flow
$52M
Beta
0.75
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine EHAB's potential to beat the market
AStrong Buy
- Stocks with a Zen Rating of Strong Buy (A) had an average return of +32.52% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
B
EHAB
Ranked#1 of 42
Ranked#1 of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $14.36 | A | |
| $3.96 | A | |
| $13.22 | A |
Be the first to know about important EHAB news, forecast changes, insider trades & much more!
EHAB News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EHAB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EHAB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EHAB is good value based on its book value relative to its share price (0.86x), compared to the US Medical Care Facilities industry average (4.56x)
P/B vs Industry Valuation
EHAB is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more EHAB due diligence checks available for Premium users.
Valuation
EHAB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.36x
Industry
16.48x
Market
30.29x
EHAB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.86x
Industry
4.56x
EHAB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EHAB's financial health
Profit margin
Revenue
$259.9M
Net Income
$17.8M
Profit Margin
6.8%
EHAB's Earnings (EBIT) of -$94.90M... subscribe to Premium to read more.
Interest Coverage Financials
EHAB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.2B
Liabilities
$662.6M
Debt to equity
1.22
EHAB's short-term assets ($211.30M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EHAB's long-term liabilities ($521.10M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EHAB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$17.9M
Investing
$20.8M
Financing
-$28.2M
EHAB's operating cash flow ($51.80M)... subscribe to Premium to read more.
Debt Coverage Financials
EHAB vs Medical Care Facility Stocks
Enhabit Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.